We are excited to be hosting Tribe Public's Next Webinar Presentation and Q&A Event which will be held Wednesday, April 13 (8:30 am PT/ 11:30 am ET). Our events are approximately 30 minutes in duration.

Mr. Steve Shum, Chief Executive Officer in CEO of INVO Bioscience (NASDAQ: INVO) will deliver a presentation titled "Democratizing Infertility - A Severely Underserved Global Market." He will be also be available for a 5-10 minute Q&A session at the end of the presentation. Send Questions to email: research@tribepublic.com.

INVO Bioscience (NASDAQ: INVO) is a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Their solution, the INVO® Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience.

Their lead product, the INVOcell®, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI).

Their mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care.

Back to Events